TEXTBOOK OF Cancer in Pregnancy About INCIP INCIP is a network established under the auspices of ESGO (European Society of Gynaecological Oncology) and aims to promote research on cancer in pregnancy. Currently, the network counts 109 members from 34 countries that cooperate together, and established an international registry on cancer during pregnancy and fertility preservation. INCIP also studies the effects of various cancer therapies of both mother and a child. Since it is counterintuitive to administer drugs that are designed to kill rapidly dividing cells to pregnant women, core in this project is the documentation of health and development in the offspring. Our results however show that the children perform as well as other children of the same gender and age. Adverse effects are more likely to occur as a consequence of premature birth than of cancer treatment during pregnancy. Together with other studies, INCIP data show the potential to treat cancer during pregnancy. The reassuring data allow a shift of the paradigm that termination of pregnancy or a medically induced preterm delivery is mandatory. Instead, we now observe a clear trend towards fewer terminations of pregnancy, more cancer treatment during pregnancy. Also, children are less likely to be born preterm. In the years to come, INCIP aims to refine the conclusions and confirm them in longer-term studies. In addition, the maternal prognosis in these cases remains our focus. Our network provides also an opportunity to invest in the study for fertility-sparing cancer treatments. We are glad to share our findings with you in this new Textbook Cancer in Pregnancy and hope that the information can be clinically useful for colleagues all over the world. Get your hard copy now Editor in Chief Frederic Amant and 57 Editors Contents: General Management Of Cancer & Pregnancy Epidemiology Imaging During Pregnancy Radiotherapy During Pregnancy Surgery During Pregnancy Targeted -, Hormonal -, Immunotherapy Chemotherapy During Pregnancy Supportive Therapy Gpsychological Challenges And Support For Pregnant Women Diagnosed With Cancer And Their Family Obstetrical Management Pediatric Long-Term Outcome After In Utero Exposure To Cancer Treatment National And International Organisation Of Cancer In Pregnancy Research And Clinical Care Specific Cancers During Pregancy Breast Cancer Cervical Intraepithelial Neoplasia (Cin) Cervical Cancer Invasive Ovarian Cancer Borderline Ovarian Tumour Acute Leukemia During Pregnancy Hodgkin Lymphoma And Non-Hodgkin Lymphoma Melanoma Gastro-Intestinal Cancer Thyroid Cancer Brain Tumours In Pregnancy Fertility Sparing Management Surgical Aspects Preventive Strategies During Radio – And/Or Chemotherapy Preventive Strategies Before Radioand/Or Chemotherapy – Oocyte And Ovarian Directly to: ESGO‘s Upcoming Conference Gynae-Cancers Algorithms App eAcademy Premium Collection ESGO‘s Journal latest articles myESGO ESGO Newsletter Get notified on all news and activities right in your mailbox. Sign-up Now! Upcoming events Conference ESGO State of the Art October 4-6, 2018 Lyon, France Save the Date! Read More Surgery Course Ovarian Cancer Surgery Course December 6 – 8, 2018 Hamburg, Germany Read More Congress ESGO 2019 Athens Congress November 2-5, 2019 Athens, Greece Save the Date! Read More European Society of Gynaecological Oncology The European Society of Gynaecological Oncology (ESGO) is the leading European organisation with more than 2,500 professionals involved in treatment, care and research of gynaecologic cancers. Contact us Explore ESGO eAcademy Journal Attend ESGO Congress SoA Conference Meetings Calendar Network Networks ENYGO ENGOT Join Become a Member myESGO Members Directory News Updates Get notified on all of ESGO’s news and activities. Sign-up Now!